Trial Summary
What is the purpose of this trial?
This trial tests if listening to Mozart's music and other suitable songs can reduce seizures in children with epilepsy. The idea is that music might calm brain activity, helping to lower seizure frequency. Promising effects of listening to Mozart on reducing seizure frequency in individuals with epilepsy have been demonstrated over time.
Do I need to stop my current medications for the music and epilepsy trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Music Stimuli, Mozart Music Therapy, Music Stimuli, Auditory Stimulation for epilepsy?
Research shows that listening to Mozart's music, particularly the Sonata for Two Pianos in D major, K.448, can reduce epileptiform discharges (abnormal brain activity) in people with epilepsy. Studies have found significant decreases in these discharges and improvements in seizure control and behavior in children with epilepsy when exposed to Mozart's compositions.12345
Is listening to recorded music, like Mozart's compositions, safe for people with epilepsy?
How is the treatment of recorded music for epilepsy different from other treatments?
Research Team
Sarah Kelley, MD
Principal Investigator
Johns Hopkins University
Eligibility Criteria
This trial is for English-speaking children aged 4 to 17 with epilepsy, who are staying in Epilepsy Monitoring Units for up to a week. Children who do not speak English cannot participate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants listen to Mozart K.448 and instrumental age-appropriate songs with washout periods in between during EMU stays
Follow-up
Participants are monitored for changes in epileptiform discharges, heart rate variability, and blood pressure variability
Treatment Details
Interventions
- Music Stimuli (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Theodore DeWeese
Johns Hopkins University
Chief Executive Officer since 2023
MD from an unspecified institution
Allen Kachalia
Johns Hopkins University
Chief Medical Officer since 2023
MD from an unspecified institution